+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Glucose Monitoring Market, By Type, By Component, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

  • PDF Icon

    Report

  • 168 Pages
  • December 2022
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5714464
Regular blood glucose monitoring is essential for diabetes management. It is the most important thing people with diabetes can do to manage Type 1 or Type 2 diabetes. Blood glucose monitoring is the use of a glucose meter to test the concentration of glucose in the blood. Self-monitoring of blood glucose (SMBG) devices are handheld devices used by patients at home to check their blood glucose levels. While, continuous glucose monitoring (CGM) devices help people manage Type 1 or Type 2 diabetes with fewer fingerstick tests. Thus, with the increase in prevalence of diabetes, the demand for blood glucose monitoring is also increasing rapidly.

Market Dynamics:

Rise in prevalence or incidence of diabetes, increase in awareness among people about diabetes management, increase in adoption of blood glucose monitoring devices, increase in research and development, increase in number of product launches, and favorable government initiatives are major factors expected to drive growth of the global blood glucose monitoring market.

For instance, in March 2021, Roche announced the launch of the new Accu-Chek Instant system, a new connected blood glucose monitoring system, which supports and enables Roche’s approach of integrated Personalized Diabetes Management (iPDM). The system features Bluetooth enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app. The app offers users quick insights to their diabetes data in addition to diabetes management features like the mySugr insulin calculator.

Moreover, in January 2019, the U.S. Food and Drug Administration (FDA) approved implantable continuous glucose monitoring (CGM) device for individuals with type 1 and type 2 diabetes. The device, called the Eversense Continuous Glucose Monitoring System, provides monitoring for up to three months, and it’s approved for people age 18 and older.

Key Features of the Study:

  • This report provides in-depth analysis of the global blood glucose monitoring market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global blood glucose monitoring market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Senseonics, Acon Laboratories Inc., Bionime Corporation, AgaMatrix Inc., Ascensia Diabetes Care, ARKRAY Inc., Medisana AG, Medtronic PLC, DexCom Inc., LifeScan Inc., Roche Diagnostics, Abbott Diabetes Care, Trivida Functional Medicine, and Rossmax International Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global blood glucose monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.

Detailed Segmentation:

Global Blood Glucose Monitoring Market, By Type:

  • Self-monitoring blood glucose devices
  • Continuous glucose monitoring devices

Global Blood Glucose Monitoring Market, By Component:

  • Glucometer devices
  • Test strips
  • Lancets
  • Sensors
  • Durables

Global Blood Glucose Monitoring Market, By Geography:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America

Company Profiles:

  • Senseonics
  • Medisana AG
  • Acon Laboratories Inc.
  • Bionime Corporation
  • AgaMatrix Inc.
  • Ascensia Diabetes Care
  • ARKRAY Inc.
  • Medtronic PLC
  • DexCom Inc.
  • LifeScan Inc.
  • Roche Diagnostics
  • Abbott Diabetes Care
  • Trivida Functional Medicine
  • Rossmax International Ltd.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Component
  • Market Snapshot, By Geography
  • Publisher Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Increase in prevalence/incidence of diabetes across the globe
  • High cost and poor reimbursement of blood glucose monitoring devices
  • Increase in adoption of blood glucose monitoring devices
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER’s Analysis
  • Merger and Acquisition Scenario
4. Global Blood Glucose Monitoring Market - Impact of Coronavirus (COVID-19) Pandemic
  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact
5. Global Blood Glucose Monitoring Market, By Type, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Self-monitoring blood glucose devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Continuous glucose monitoring devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Blood Glucose Monitoring Market, By Component, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Glucometer devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Test strips
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Lancets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Sensors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Durables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Global Blood Glucose Monitoring Market, By Geography, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
8. Competitive Landscape
  • Senseonics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Medisana AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Acon Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Bionime Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • AgaMatrix Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Ascensia Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • ARKRAY Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Medtronic PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • DexCom Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • LifeScan Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Abbott Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Trivida Functional Medicine
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Rossmax International Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Analyst Views
9. Section
  • Research Methodology
  • About the Author

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Senseonics
  • Medisana AG
  • Acon Laboratories Inc.
  • Bionime Corporation
  • AgaMatrix Inc.
  • Ascensia Diabetes Care
  • ARKRAY Inc.
  • Medtronic PLC
  • DexCom Inc.
  • LifeScan Inc.
  • Roche Diagnostics
  • Abbott Diabetes Care
  • Trivida Functional Medicine
  • Rossmax International Ltd.